scholarly article | Q13442814 |
P2093 | author name string | Mohamadreza Baghaban Eslaminejad | |
Shahrbanoo Jahangir | |||
P2860 | cites work | Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis | Q21142646 |
Primary structure and functional expression of rat and human stem cell factor DNAs | Q24297190 | ||
Mesenchymal precursor cells in the blood of normal individuals | Q24792739 | ||
Establishment in culture of pluripotential cells from mouse embryos | Q27860625 | ||
Identification of stem cells in small intestine and colon by marker gene Lgr5 | Q28131701 | ||
BIOLOGY OF HEMATOPOIETIC STEM CELLS AND PROGENITORS: Implications for Clinical Application | Q29397118 | ||
Mammalian neural stem cells | Q29547657 | ||
Human embryonic stem cells express a unique set of microRNAs | Q29617079 | ||
Tissue engineering | Q29617288 | ||
Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol | Q30164154 | ||
Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. | Q30167892 | ||
Mesenchymal progenitor cells in human umbilical cord blood | Q30168979 | ||
The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). | Q30807148 | ||
Adult human olfactory stem cells | Q31871550 | ||
Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds | Q33621125 | ||
Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells | Q33934154 | ||
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone | Q34066339 | ||
The amniotic fluid as a source of cells for fetal tissue engineering | Q34099714 | ||
Cardiac repair with injectable cell sheet fragments of human amniotic fluid stem cells in an immune-suppressed rat model. | Q34125426 | ||
Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts | Q34135210 | ||
The evolving concept of a stem cell: entity or function? | Q34299883 | ||
Neurogenic cells in human amniotic fluid. | Q34338842 | ||
Tissue engineering: orthopedic applications | Q34432995 | ||
Ontogeny of tracheal fluid, pulmonary surfactant, and plasma corticoids in the fetal lamb | Q34465179 | ||
Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro | Q34585061 | ||
Isolation of amniotic stem cell lines with potential for therapy | Q34598404 | ||
The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells | Q34704081 | ||
Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application | Q34749244 | ||
Generation of pluripotent stem cells from adult human testis. | Q34851175 | ||
Amniotic membrane and amniotic fluid-derived cells: potential tools for regenerative medicine? | Q34968140 | ||
Amniotic fluid cells and human stem cell research: a new connection. | Q35005532 | ||
Mesenchymal stem cell therapy in joint disease | Q35112276 | ||
Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages | Q35215695 | ||
Potential use of stem cells in neuroreplacement therapies for neurodegenerative diseases. | Q35604539 | ||
Plasticity of adult stem cells | Q35684656 | ||
Endothelial progenitor cells: characterization and role in vascular biology | Q35867837 | ||
Amniotic fluid and placental stem cells | Q35975210 | ||
Updates on stem cells and their applications in regenerative medicine | Q37169200 | ||
Escalated regeneration in sciatic nerve crush injury by the combined therapy of human amniotic fluid mesenchymal stem cells and fermented soybean extracts, Natto | Q37336834 | ||
Amniotic fluid stem cells produce robust mineral deposits on biodegradable scaffolds. | Q37471397 | ||
Mesenchymal stem cells for bone repair and metabolic bone diseases. | Q37606972 | ||
Enhancement of regeneration with glia cell line-derived neurotrophic factor-transduced human amniotic fluid mesenchymal stem cells after sciatic nerve crush injury | Q39789438 | ||
Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage. | Q39915733 | ||
Post-injury regeneration in rat sciatic nerve facilitated by neurotrophic factors secreted by amniotic fluid mesenchymal stem cells. | Q40063797 | ||
Amniotic fluid cell types and culture | Q40162698 | ||
Morphological and biochemical heterogeneity of amniotic fluid cells in culture | Q40245302 | ||
Stable expression of a neuronal dopaminergic progenitor phenotype in cell lines derived from human amniotic fluid cells. | Q40300770 | ||
Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells | Q40370235 | ||
Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? | Q40578057 | ||
Surface antigens of human embryonic stem cells: changes upon differentiation in culture | Q40729324 | ||
Human and ovine amniotic fluid composition differences: implications for fluid dynamics | Q41666728 | ||
Cell sourcing for bone tissue engineering: amniotic fluid stem cells have a delayed, robust differentiation compared to mesenchymal stem cells. | Q41977244 | ||
Human amniotic fluid stem cells seeded in fibroin scaffold produce in vivo mineralized matrix | Q42016149 | ||
Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells | Q42444844 | ||
Simultaneous decrease of telomere length and telomerase activity with ageing of human amniotic fluid cells | Q43076377 | ||
Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium | Q44872746 | ||
Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion | Q45877573 | ||
Amniotic fluid-derived mesenchymal stem cells lead to bone differentiation when cocultured with dental pulp stem cells | Q46295546 | ||
Fibroin scaffold repairs critical-size bone defects in vivo supported by human amniotic fluid and dental pulp stem cells | Q47338383 | ||
A brief definition of regenerative medicine | Q48012344 | ||
Mesenchymal cells from human amniotic fluid survive and migrate after transplantation into adult rat brain | Q48231502 | ||
Amniotic fluid stem cell migration after intraperitoneal injection in pup rats: implication for therapy | Q48424619 | ||
Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. | Q50472629 | ||
Chondrogenic differentiation of amniotic fluid-derived stem cells. | Q50946606 | ||
Fetal cartilage engineering from amniotic mesenchymal progenitor cells. | Q51214953 | ||
Diaphragmatic repair through fetal tissue engineering: a comparison between mesenchymal amniocyte- and myoblast-based constructs. | Q51288629 | ||
The biological characteristics of human third trimester amniotic fluid stem cells. | Q51822929 | ||
Mesenchymal stem cells from murine amniotic fluid as a model for preclinical investigation. | Q51887580 | ||
Ion fluxes across the pulmonary epithelium and the secretion of lung liquid in the foetal lamb. | Q52439406 | ||
Combination of G-CSF administration and human amniotic fluid mesenchymal stem cell transplantation promotes peripheral nerve regeneration. | Q52588556 | ||
Amniotic fluid dynamics. | Q55038779 | ||
Stem cells in the testis | Q57280271 | ||
Murine mesenchymal stem cells isolated by low density primary culture system | Q57777088 | ||
The SH-3 and SH-4 Antibodies Recognize Distinct Epitopes on CD73 from Human Mesenchymal Stem Cells | Q60505213 | ||
Origin of cells in human amniotic fluid cultures: ultrastructural features | Q67369945 | ||
Osteogenesis in transplants of bone marrow cells | Q71202383 | ||
Current concepts of amniotic fluid dynamics | Q71348005 | ||
Identification of hematopoietic progenitor cells in human amniotic fluid before the 12th week of gestation | Q72606471 | ||
[In vitro transformation of amniotic cells to muscle cells--background and outlook] | Q73022633 | ||
Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy | Q73358706 | ||
Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation | Q73658957 | ||
Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation | Q73756569 | ||
Tissue-engineered bone regeneration | Q74268240 | ||
Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome | Q79352056 | ||
Cellular cardiomyoplasty with human amniotic fluid stem cells: in vitro and in vivo studies | Q82475836 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 147-156 | |
P577 | publication date | 2012-10-01 | |
P1433 | published in | International journal of fertility & sterility | Q26842173 |
P1476 | title | Amniotic fluid stem cells and their application in cell-based tissue regeneration | |
P478 | volume | 6 |
Q26774930 | A Mini Overview of Isolation, Characterization and Application of Amniotic Fluid Stem Cells |
Q99417970 | Activation of Wnt signaling by amniotic fluid stem cell-derived extracellular vesicles attenuates intestinal injury in experimental necrotizing enterocolitis |
Q55220429 | Placenta and Placental Derivatives in Regenerative Therapies: Experimental Studies, History, and Prospects. |
Search more.